Recent Updates
Recently added Catalysts
EVAX Negative Sentiment Score: 30/100

OF EXTRAORDINARY GENERAL MEETING

Key Takeaway: Evaxion Biotech A/S announces an extraordinary general meeting scheduled for January 2025, where the board will propose significant changes to the company's share capital. This includes reducing the nominal share capital from DKK 58,660,556 to DKK 14,665,139 due to losses. Additionally, the nominal value of each share is set to change from DKK 1 to DKK 0.25. The company aims to authorize adjustments to issued warrants to reflect these changes.

Market Sentiment Analysis

CONCERNS & RISKS

  • The company is proposing a significant reduction in its share capital to cover losses.
  • The nominal value of the shares is being reduced, indicating financial difficulties.

Full Press Release Details

OF EXTRAORDINARY GENERAL MEETING
JANUARY 2025 AT 15:00 (CET)
board of directors hereby convenes an extraordinary general meeting of Evaxion Biotech A/S, company registration (CVR) no. 31 76 28 63
(the "Company"), to be held on
January 2025 AT 15:00 (CET)
Evaxion Biotech A/S, Dr Neergaards Vej 5F, DK-2970 H rsholm, Denmark.
board of directors proposes that attorney-at-law Lars L thjohan be elected as chairman of the general meeting.
board of directors proposes to reduce the Company's share capital by nominal DKK 43,995,417 from nominal DKK 58,660,556 to nominal
DKK 14,665,139 to cover loss.
the board of directors proposes to reduce the nominal value of the shares from nominal DKK 1 per share to nominal DKK 0.25 per share.
board of directors specifically proposes that the existing article 2.1 is amended as follows:
share capital is nominal DKK 14,665,139 divided into 58,660,556 shares of nominal DKK 0.25 each or any multiples hereof."
are informed that issued warrants will be adjusted by the board of directors pursuant to applicable adjustment clauses to reflect the
changes to the share capital. For the avoidance of doubt, no amendents will be made to existing authorisations to the board of directors
to issue shares, convertible bonds and/or warrants.
board of directors proposes to authorize the chairman of the meeting (with a right of substitution) on behalf of the Company to apply
the Danish Business Authority for registration of the resolutions passed by the General Meeting and in this connection to make any such
amendments to the documents prepared for such resolutions that may be required for regis-tration with the Danish Business Authority.
Denmark, 20 December 2024
board of directors of Evaxion Biotech A/S
of the board of directors
proposals contained in item 1 and 3, may be adopted by a simple majority of the votes cast.
proposal under the agenda's item 2 may be adopted by a majority of not less than two thirds of all votes cast and of the share
capital represented at the general meeting.
capital and voting rights
Company's nominal share capital currently amounts to DKK 58,660,556 divided into 58,660,556 shares of DKK 1.00 nominal value. At the
extraordinary general meeting, each share carries one vote.
right of a shareholder to attend the annual general meeting and to vote in respect of his/her shares is determined on the basis of the
shares held by the shareholder at the record date. The shareholdings and voting rights are calculated on the basis of entries in the
register of shareholders and any notice of own-ership received by the Company for the purpose of registration in the register of shareholders.
record date is 10 January 2025.
participation is conditional upon the shareholder having timely notified the Company of his/her attendance as described below.
proxies and any accompanying advisor wishing to attend the annual general meeting in person must have an admission card. Admission cards
may be ordered on the website of Computershare A/S: www.computershare.com.
cards must be ordered no later than 13 January 2025 at 23:59 (CET).
can vote by proxy no later than 13 January 2025 at 23:59 (CET).
proxy can be submitted in writing by using the proxy form which is attached to the convening notice and can be downloaded from the Company's
website: www.evaxion.ai. If the form is used, it must be completed, signed and forwarded to
Computershare A/S, Lottenborgsvej 26 D, 1st floor, DK-2800 Kgs. Lyngby, Denmark, by mail. Computershare must receive completed proxy
forms no later than 13 January 2025 at 23:59 (CET).
may also be granted electronically on the website of Computershare, www.computershare.dk,
by using a Computershare username and password. Usernames and passwords will be sent to all shareholders by email. Electronic proxies
must be granted no later than 13 January 2025 at 23:59 (CET).
can vote by correspondence no later than 16 January 2025 at 11:59 (CET).
vote by correspondence can be submitted in writing by using the correspondence form which is at-tached to convening notice and can be
downloaded from the Company's website: www.evaxion.ai. If the form is used, it must be completed,
signed and forwarded to Computershare A/S, Lottenborgsvej 26 D, 1st floor, DK-2800 Kgs. Lyngby, Denmark, by mail.
is also possible to vote electronically on the website of Computershare A/S, www.computershare.dk,
by using a Computershare username and password.
the Company's website, www.evaxion.ai, the following information is available no later than
convening notice will also be forwarded in writing to all shareholders recorded in the register of share-holders who have requested such
extraordinary general meeting will be conducted in English according to section 4.8 of the Company's articles of association.

Frequently Asked Questions

When is the extraordinary general meeting of Evaxion Biotech?

The extraordinary general meeting is scheduled for January 2025 at 15:00 (CET).

Who is proposed as the chairman of the meeting?

Attorney-at-law Lars L thjohan is proposed to be the chairman.

What is the proposed share capital reduction?

The share capital is proposed to reduce from DKK 58,660,556 to DKK 14,665,139.

What is the record date for shareholders?

The record date for shareholders is set for January 10, 2025.

How can shareholders vote by proxy?

Shareholders can vote by proxy using a form or electronically via Computershare.

Last updated: Dec 26, 2024